MedPath

Intervention pilot with fibrinogen concentrate and the combination of fibrinogen concentrate with FFP in patients with massive post/peri-operative bleeding problems

Conditions
general surgery patients, heart valve replacement, peri/post operative bleeding problemsalgemene chirurgie patiënten, hartklep vervanging, peri/post operatieve bloedingsproblemen
Registration Number
NL-OMON24904
Lead Sponsor
dr. JWM. HeemskerkP.I. CARIM
Brief Summary

Main resource:<br> Mittermayr M et al. Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery:the role of fibrinogen administration. Anesth Analg. 2007; 105

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
100
Inclusion Criteria

1. General surgery patients with massive peri-operative bloodloss, with an indication of receiving 4 units of FFP according to current guidelines.

2. Cardiothoracic surgery patients after heart valve replacement who met the criteria of increased bloodloss and indication for DDAVP.

Exclusion Criteria

1. No other therapeutical anti-thrombotica are given, other than platelet-aggregation inhibitors

2. Patients with active HIV-infection

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Stop of bleeding after the therapy. The clinical situtation after the treatment will be compared with conventional coagulation tests (aPTT, PT, fibrinogen level).
Secondary Outcome Measures
NameTimeMethod
Thrombin generation and thromboelastography measurements, measured with the CAT en TEG method.
© Copyright 2025. All Rights Reserved by MedPath